Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
September 06, 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical CareSeptember 06, 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Key contacts
Lee Harris Partner United Kingdom Antony Walsh Partner United Kingdom Barri Mendelsohn Partner United Kingdom Rachel Cooper Partner United Kingdom Edward M. Tompkin-Haag Partner United Kingdom Kelly Holmes Partner United Kingdom Philip Crosbie Partner United Kingdom Christopher Murray Partner United Kingdom Latest Insights
Latest News
Latest Events
legal updates September 03, 2026 CC/Devas v India: Sovereign immunity survives New York Convention legal updates September 02, 2026 Commercially Connected shorts - 2 September 2026 legal updates September 02, 2026 Increase in the amount of corporate fines legal updates September 01, 2026 Germany: regulator publishes draft determination for electricity grid charg... client news September 03, 2026 We advised TMF Finland Oy on its acquisition of Navigator Partners Oy client news September 01, 2026 We advised Ilkka Oyj on its acquisition of Custobar Oy firm news August 26, 2026 Eversheds Sutherland strengthens top-ranked pensions practice with appointm... client news August 25, 2026 We advised Merus Power on its EPC supply agreement with Exilion virtual UAE - Employment law in the Dubai International Financial Centre September 10, 2026 9.30am - 1.30pm (GMT) Virtual in-person Managing AI use in the workplace: what every UK HR team needs to know September 10, 2026 9.30am - 1.00pm (BST) London, United Kingdom in-person Basic foundations of US employment law September 17, 2026 9.30am - 4.30pm (GMT) London, United Kingdom in-person 2026 BDC Roundtable September 23, 2026 Washington DC, United States |